Navigation Links
Researchers Spot Potential Bile Duct Cancer Drug Targets
Date:1/26/2012

THURSDAY, Jan. 26 (HealthDay News) -- Researchers who identified a new genetic signature associated with bile duct cancer say their discovery could lead to targeted treatment for the deadly cancer.

The team at the Massachusetts General Hospital Cancer Center screened samples from 287 patients with gastrointestinal tumors and found that growth-enhancing mutations in two genes (IDH1 and IDH2) may account for nearly one-fourth of bile duct tumors that develop in the liver.

Mutations in IDH1 were found in 13 percent of all bile duct tumors and in 23 percent of those within the liver itself. Mutations in IDH2 were less common.

It may be possible to develop drugs that target this mutation in order to control tumor growth, they said.

The findings were published online in The Oncologist.

Bile duct cancer occurs in a duct that carries bile from the liver to the small intestine.

"Patients with bile duct cancer have a generally poor prognosis. Most of them are diagnosed with advanced or metastatic disease, so surgical resection [removal] is not feasible," study co-senior author Dr. Andrew Zhu, director of Liver Cancer Research at the MGH Cancer Center, said in a hospital news release.

"Identifying this new and relatively common mutation in intrahepatic [within the liver] bile duct cancer may have significant implications for the diagnosis, prognosis and therapy of patients whose tumors harbor this mutation," Zhu added.

Currently, there are no drugs that target IDH mutations, but extensive efforts are underway to develop such drugs, the researchers say.

Each year in the United States, 12,000 people are diagnosed with cancers of the gallbladder and bile duct, but only 10 percent of those cancers are discovered early enough for successful surgical treatment. Average survival, even with chemotherapy, is less than a year.

More information

The American Cancer Society has more about bile duct cancer.

-- Robert Preidt

SOURCE: Massachusetts General Hospital, news release, Jan. 18, 2012


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Georgetown Lombardi researchers present new findings on head & neck cancers
2. Researchers discover method to unravel malarias genetic secrets
3. Researchers quantify muscle soreness
4. Georgetown professor applauds decision of researchers to temporarily halt research on H5N1
5. Health benefits of exercise may depend on cellular degradation, UT Southwestern researchers report
6. Autism redefined: Yale researchers study impact of proposed diagnostic criteria
7. University of Tennessee researchers develop comprehensive, accessible vision testing device
8. Lawson researchers engineer a switch to tame aggressive cancers
9. UC Davis researchers refine nanoparticles for more accurate delivery of cancer drugs
10. Researchers study how chemicals in drugs and around us impact stem cells
11. University of Granada researchers identify changes in tumor cells that lead to metastasis
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Researchers Spot Potential Bile Duct Cancer Drug Targets 
(Date:9/20/2017)... Texas (PRWEB) , ... September 20, 2017 , ... ... in the Orthodontics and Clear Aligner clinical and commercial support services market) has ... of Dentistry (PGSD) in Sydney, Australia. , The PGSD is the first ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... In just ... Brain Booster has already been receiving positive feedback from customers trying the product for ... , Daily Brain Booster was developed by neurosurgeon Shawn Moore, MD, for everyone ...
(Date:9/20/2017)... , ... September 20, 2017 , ... ... of older Americans at risk of price gouging for their prescription drugs, according ... (TSCL) . “Because Medicare isn’t negotiating on our behalf, there’s no consistency in ...
(Date:9/20/2017)... ... , ... “RECYCLED Ezekiel's Plan for Freedom from ADDICTION”: A ... is the creation of published author, Bill Miller. Bill Miller has a ... more than a decade of addiction to prescription drugs. He has a ...
(Date:9/20/2017)... , ... September 20, 2017 , ... “Psalms of Humidity”: ... peace of mind and move the readers one step closer to God. “Psalms of ... realized that his mistakes that have been made within his life are the very ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... N.Y. , Sept. 6, 2017   PDI , ... announced it will host an educational session focused on ... bloodstream infection (CLABSI) prevention at the 2017 Annual Scientific ... which will take place at the Phoenix ... from Sept. 16-19, will also feature PDI,s ...
(Date:9/5/2017)... N.J. , Sept. 5, 2017  Getinge, ... has created a vibrant charitable donation program -- ... and support congenital heart defect research by The ... providers and the general public are encouraged to ... and submit the completed artwork to the gallery ...
(Date:9/1/2017)... 1, 2017  Bayer will present the latest research from ... Medical Oncology (ESMO) 2017 Congress, September 8-12 in ... preclinical and clinical data on Bayer,s marketed portfolio and late-stage ... "We value the ... cancer research at ESMO," said Carsten Brunn , Head ...
Breaking Medicine Technology: